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Disruption of a Ciliary B9 Protein Complex
Causes Meckel Syndrome
William E. Dowdle,1 Jon F. Robinson,2 Andreas Kneist,3 M. Salome´ Sirerol-Piquer,4
Suzanna G.M. Frints,5,6 Kevin C. Corbit,1 Norran A. Zaghloul,2,7 Gesina van Lijnschoten,8
Leon Mulders,9 Dideke E. Verver,6,10 Klaus Zerres,3 Randall R. Reed,11 Tania Attie´-Bitach,12
Colin A. Johnson,13 Jose´ Manuel Garcı´a-Verdugo,10,14 Nicholas Katsanis,2,16,* Carsten Bergmann,3,15,16,*
and Jeremy F. Reiter1,16
Nearly every ciliated organism possesses three B9 domain-containing proteins: MKS1, B9D1, and B9D2. Mutations in human MKS1
cause Meckel syndrome (MKS), a severe ciliopathy characterized by occipital encephalocele, liver ductal plate malformations, polydac-
tyly, and kidney cysts. Mouse mutations in either Mks1 or B9d2 compromise ciliogenesis and result in phenotypes similar to those of
MKS. Given the importance of these two B9 proteins to ciliogenesis, we examined the role of the third B9 protein, B9d1. Mice lacking
B9d1 displayed polydactyly, kidney cysts, ductal plate malformations, and abnormal patterning of the neural tube, concomitant with
compromised ciliogenesis, ciliary protein localization, and Hedgehog (Hh) signal transduction. These data prompted us to screen
MKS patients for mutations in B9D1 and B9D2. We identified a homozygous c.301A>C (p.Ser101Arg) B9D2 mutation that segregates
withMKS, affects an evolutionarily conserved residue, and is absent from controls. Unlike wild-type B9D2mRNA, the p.Ser101Argmuta-
tion failed to rescue zebrafish phenotypes induced by the suppression of b9d2. With coimmunoprecipitation and mass spectrometric
analyses, we found that Mks1, B9d1, and B9d2 interact physically, but that the p.Ser101Arg mutation abrogates the ability of B9d2
to interact with Mks1, further suggesting that the mutation compromises B9d2 function. Our data indicate that B9d1 is required for
normal Hh signaling, ciliogenesis, and ciliary protein localization and that B9d1 and B9d2 are essential components of a B9 protein
complex, disruption of which causes MKS.Introduction
Meckel syndrome (MKS [MIM 249000]) is a rare autosomal-
recessive disorder resulting in perinatal lethality and
characterized by renal cysts, hepatic ductal plate malfor-
mation, and central nervous system defects, such as occip-
ital encephalocele.1 Mutations in six genes are known to
cause MKS: MKS1 (MIM 609883), TMEM216 (MKS2 [MIM
613277]), TMEM67 (MKS3 [MIM 609884]), CEP290 (MKS4
[MIM 610142]), RPGRIP1L (MKS5 [MIM 610937]), and
CC2D2A (MKS6 [MIM 612013]).2–7 In addition, mutations
in NPHP3 (MKS7 [MIM 608002]) and TCTN2 (MKS8) cause
MKS-like phenotypes.8,9 The products of these genes
localize to cilia and/or basal bodies, supporting the
hypothesis that ciliary dysfunction underlies MKS.
MKS1, a variant of which was the first gene linked to
MKS, encodes a protein containing a B9 domain, structur-
ally similar to the lipid binding domains of the C21Department of Biochemistry and Biophysics, and Cardiovascular Research Inst
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nized MKS proteins contain B9 domains, bilaterians
including mammals, Drosophila, and C. elegans possess
two other B9 domain-containing proteins, B9d1 and
B9d2 (also known as Stumpy [MIM 611951]). B9 domain-
containing proteins are also present in diverse ciliated
protists, including Trypanosomes, Naegleria, and Batra-
chochytrium, but are absent from nonciliated eukaryotes,
includingmost yeast and higher plants (see Figure S1 avail-
able online). Consistent with a role in cilia function, all
three B9 domain proteins localize to the transition zone
of C. elegans cilia or the basal body and axoneme of
mammalian cilia.11–14 Mouse embryos homozygous for a
loss-of-function mutation in Mks1 display hallmarks of
MKS, such as renal cysts, ductal plate malformation, and
brain malformations similar to occipital meningoencepha-
locele. In addition, thesemutants displayed cleft palate and
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(MIM 249000).13,15–18 Conditional inactivation of B9d2 in
the brain and kidney cause hydrocephalus and renal cysts,
accompanied by defects in ependymal and kidney cilia.14
Primary cilia are required for mammalian development,
in part because of their roles in mediating Hh signal trans-
duction.19 Hh signals participate in the patterning of
a large number of tissues, including the neural tube and
limb buds. Components of the Hh pathway, including
Patched1 (Ptc1), Smoothened (Smo), and the Gli transcrip-
tional effectors, localize to primary cilia, suggesting that
critical Hh signal transduction events occur within
cilia.20–22 Consistent with this hypothesis, vertebrate
mutations that disrupt ciliogenesis cause defects in Hh
signaling and concomitant developmental phenotypes.23
To investigate further the role of B9 proteins in ciliogen-
esis and in the pathogenesis of MKS, we analyzed mice
mutant for the third member of the B9 genes, B9d1. Strik-
ingly, loss of B9d1 resulted in MKS-like phenotypes in
mouse embryos which, taken together with the mouse
mutant data for B9d2, suggested that these two loci are
candidates for causing severe ciliopathies. Therefore, we
screened MKS fetuses for mutations in B9D1 and B9D2
and identified a homozygous mutation in B9D2. We also
found that all three B9 proteins interact physically with
each other but that the MKS-associated disease allele of
B9d2 exhibited decreased affinity for Mks1. These findings
reveal that a complex comprised of the three B9 proteins
support mammalian ciliogenesis, disruption of which
results in Hh signaling defects and MKS.Material and Methods
B9 Protein Conservation
We identifiedMKS1, B9D1, and B9D2orthologs by using reciprocal
best match by BLAST. MKS1 orthologs include Tetrahymena
TTHERM_00630490, Batrachochytrium BDEG_00264, Trico-
plax JGI 61316, and Naegleria JGI 29577. B9D1 orthologs
include Batrachochytrium BDEG_03036, Chlamydomonas
Au9.Cre01.g066000, Paramecia GSPATP00029931001, Tetrahy-
mena TTHERM_00219110, Leishmania major LmjF32.0280,
Trypanosoma bruceiTb10.61.2290, Trichoplax JGI 52971,Monosiga
JGI 24999, Naegleria JGI 52666, Thalassiosira JGI 264691, and
Phytophthora JGI 71279. B9D2 orthologs include Batrachochy-
trium BDEG_03725, Chlamydomonas Au9.Cre03.g196050, Nae-
gleria JGI 30379, Trypanosoma brucei Tb11.03.0750, Leishmania
major LmjF25.0320, Tetrahymena TTHERM_00633350, Parame-
cium ICIS-1, Trichoplax JGI 52819, Monosiga JGI 17074, and
Thalassiosira JGI 38153. Protein sequences were aligned with the
IDweightmatrix ofClustalW, and the alignmentwas used to create
an unrooted nearest-joining tree.Mouse Strains
All mouse protocols were approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of California,
San Francisco. B9d1þ/mice (B9d1tm1a(EUCOMM)Wtsi) were obtained
from the European Conditional Mouse Mutagenesis Program
(EUCOMM). The targeted mutation was made in C57BL/6N ES
cells, which were injected into B6(Cg)-Tyrc-2J/J blastocysts. TheThe Amice were maintained by crossing to C57BL/6J mice (Jackson
Laboratory). The mixed background strain was created by out-
crossing B9d1þ/ mice with CD1 mice (Charles River Laboratory)
for two generations. The B9d1 conditional allele was created by
crossing B9d1tm1a(EUCOMM)Wtsi mice to mice expressing FLPe re-
combinase (Tg(ACTFLPe)9205Dym/J) to remove the En2 splice
acceptor and bGeo cassette (B9d1flox/flox). Subsequently,
B9d1flox/flox mice were crossed to mice expressing Cre recombinase
(Tg(ACTB-cre)2Mrt/J) to delete exon 3. We considered noon on the
day a copulation plug was detected to be 0.5 days postcoitus.Immunohistochemistry, Histology, and In Situ
Hybridization
For whole-mount staining of nodes, E8.0 embryos were dissected
in PBS þ 10% FBS, rinsed in PBS, and fixed in 4% paraformalde-
hyde (PFA) in PBS for 30 min on ice, blocked for 30 min in 2%
BSA þ 5% donkey serum in PBS þ 0.1% Triton X-100 (PBT), and
incubated with primary antibodies overnight at 4C in 2% BSA þ
1% donkey serum in PBT. For neural tube analysis, E9.5 embryos
were harvested in PBS þ 10% FBS, rinsed in PBS, and fixed for
1 hr in 4% PFA in PBS on ice. Embryos were equilibrated in 30%
sucrose overnight and mounted in O.C.T. mounting media
(Fisher). 12 mm sections were stained as previously described.24
For liver and kidney analysis, organs were fixed in 10% formalin
overnight at 4C, sectioned, and stained with hematoxylin and
eosin according to standard protocols. Immunofluorescent stain-
ing of liver and kidney sections was performed as described.25
Biotinylated lectin staining of kidney sections was performed as
described,26 with the exception that avidin/biotin blocking solu-
tion (Vector Labs) was applied according to the manufacturer’s
instructions after sections were dewaxed.
The antibodies employedweremouse a-acetylated tubulin 6-11B-
1 (1:1,000, Sigma), rabbit a-Ninein (1:20,000, gift of James
Silbourne), mouse a-E-cadherin (1:100, BD), mouse a-Sox9 (1:100),
goat a-g tubulin (1:100, Santa Cruz Biotechnology), mouse a-Cyto-
keratin-19 (1:130, Novacastra), rabbit a-Pax6 (1:100, Covance),
mouse a-Nkx2.2 (1:20), mouse a-FoxA2 (1:20), and mouse a-Islet1/
2 (1:20, Developmental Studies Hybridoma Bank). These last three
antibodies were developed under the auspices of the NICHD and
maintained by the Department of Biological Sciences, The Univer-
sity of Iowa (Iowa City, IA). Biotinylated lectins employed were Do-
lichos biflorusagglutinin (10mg/ml,VectorLabsB-1035) andLotus tet-
ragonolobus lectin (10 mg/ml, Vector Lab B-1325). Subsequent to
secondary antibody staining with Avidin-conjugated Alexa 488
(1:300, Invitrogen), nodal and neural tube cilia were observed with
a Nikon C1 spectral confocal microscope. Neural tube pattern as
well as cilia staining of liver and kidney sections were observed
with a Leica SP5 confocal microscope. Kidney and liver H&E as
well as Sox9 and E-cadherin staining of liver sections were observed
withaZeissObserverD1 inverted epifluorescentmicroscope. Postac-
quisition image processing was performed with Metamorph
imaging software (Molecular Devices) or Image J (NIH).
To visualize cartilage, E13.5 embryos were harvested in PBS þ
10% FBS, frozen at 20, and stained with alcian blue as
described.27 In situ hybridization was performed as des-
cribed.27,28 Cartilage preparations and whole-mount embryos
were observed with a Zeiss Discovery V12 steREO microscope.Electron Microscopy
For SEM analysis, E8.0 (2–3 somite) embryos were fixed for 1 hr in
2% sodium cacodylate buffer, postfixed in 1% osmium tetroxidemerican Journal of Human Genetics 89, 94–110, July 15, 2011 95
in sodium cacodylate buffer, and dehydrated through a graded
ethanol series. Samples were mounted on aluminum stubs with
carbon dots, critical point dried in a Tousimis AutoSamdri 815,
and sputter coated with gold in a Tousimis chamber. Samples
were visualized on a Hitachi S-5000 scanning electronmicroscope.
For TEM analysis, E9.5 embryos were fixed for 24 hr at RT in 0.1 M
phosphate buffer (pH 7.4, PB) containing 2% paraformaldehyde
and 2.5% glutaraldehyde. Embryos were rinsed in PB and post-
fixed for 2 hr with 2% osmium tetroxide. After a graded ethanol
dehydration series and propylene oxide infiltration, embryos
were embedded in Araldite resin (Durcupan, Fluka). To select the
area of interest, we cut semithin sections (1.5 mm) with a diamond
knife and stained with 1% toluidine blue. Subsequently, we cut
ultrathin sections (60–90 nm) from the area of interest with
a diamond knife, stained them with lead citrate, and examined
them with a Fei Tecnai Spirit electron microscope.Plasmid Construction
pGLAP5-Rer1, pGLAP5-Mks1, pGLAP5-B9d1, pGLAP5-B9d2, pEF/
V5/Frt-Rer1, pEF/V5/Frt-Mks1, pEF/V5/Frt-B9d1, and pEF/V5/Frt-
B9d2 were created by polymerase chain reaction (PCR) amplifica-
tion of the coding sequences from verified mouse cDNA clones
(Open Biosystems). PCR products were TOPO cloned into the
pCR8/GW/TOPO Gateway entry vector (Invitrogen) and recom-
bined subsequently into either pGLAP5 (Addgene plasmid
19706)29 or pEF/V5/Frt (Invitrogen) destination vectors with Clo-
nase II (Invitrogen). The B9d2 p.Ser101Arg mutation was intro-
duced into pCR8/GW/-B9d2 via site directed mutagenesis with
Quikchange II XL (Agilent). pCR8/GW-B9d2 S101R was used to
create pGLAP5-B9d2 S101R and pEF/V5/Frt-B9d2 S101R via
recombination, as described above. The p.Ser101Arg mutation
was introduced into human B9D2 cDNA clone IOH4997 of the
Invitrogen ORF collection with QuickChange site-directed muta-
genesis (Agilent). Wild-type and p.Ser101Arg B9D2 cDNAs were
cloned into pEGFP-N1 (Clontech) to generate pGFP-wtB9D2 or
pGFP-B9D2-S101R. B9D2 and B9D2-S101R were subcloned into
the pCS2þ Gateway destination vector (Invitrogen) from
pENTR221 (Invitrogen) with Clonase II (Invitrogen) to generate
pCS2-wtB9D2 or pCS2-B9D2-S101R.Cell Culture, Immunofluorescence, and Microscopy
hTERT-RPE1 cells were grown to 70% confluency in DMEM/F12
media supplemented with 10% FBS and transfected with pGFP-
wtB9D2 or pGFP-B9D2-S101R with FUGENE6 (Invitrogen). 18 hr
posttransfection, cells were switched to low-serum (0.5% FBS)
medium; 48 hr after serum starvation, the cells were washed
with PBS and fixed in 4% PFA, permeabilized, and blocked with
PBS-T (0.1% Triton X-100) containing 10% goat serum, stained
with primary antibodies as indicated, and observed with a Zeiss
LSM 510 META confocal microscope.
B9d1 wild-type and mutant MEFs were derived from E12.5
mouse embryos, as described, and grown in DMEM þ 15%
FBS.27 For Smo localization analysis, MEFs were grown to conflu-
ency, starved in Opti-MEM (Invitrogen) for 24 hr, and treated for
6 hr with 1 mM of the small molecule Smoothened AGonist
(SAG) (Enzo Life Sciences) in dimethyl sulfoxide (DMSO, Sigma).
MEFs were then fixed in 4% PFA for 5 min at 37C and 20C
methanol for 3 min. For analysis of Hh pathway activation,
MEFs were treated for 20 hr with 1 mM SAG.
Antibodies employed were rabbit a-Smo (1:100), rabbit a-Ift88
(1:100, Proteintech), rabbit a-Arl13b (1: 1,5000, gift of Tamara96 The American Journal of Human Genetics 89, 94–110, July 15, 201Caspary), rabbit a-ACIII (1:100, Santa Cruz Biotechnology), mouse
a-acetylated tubulin 6-11B-1 (1:1,000, Sigma), and goat a-g
tubulin (1:100, Santa Cruz Biotechnology). Smo antibodies were
generated by injection of a Smo-MBP fusion protein comprising
the C-terminal tail of mouse Smo into rabbits (Pacific Immu-
nology) and affinity purified with recombinant GST-Smo C
terminus.qRT-PCR
For analysis of Hh pathway activation, RNA was extracted from
MEFs with an RNAeasy kit (QIAGEN), and cDNA synthesis was
performedwith aMaxima first-strand cDNA synthesis kit (Fermen-
tas). qRT-PCR was performed with Maxima SYBR Green qPCR 2x
master mix with ROX (Fermentas) and primers homologous to
Ptch1, Gli1, and b-actin (Table S2) on an ABI 7900HT real-time
PCR machine. Levels of Ptch1 and Gli were normalized to levels
of b-actin. The qRT-PCR of each RNA sample was performed in
quadruplicate and the experiment was replicated. The fold
increase is the average of the fold increase of the Ptch1 or Gli1
mRNA levels (normalized to b-actin) in the experimental treat-
ments compared to the average of the Ptch1 or Gli1 mRNA levels
(normalized to b-actin) in the vehicle-only control. Error bars
represent the standard deviation. Statistical significance was as-
sessed with Student’s t test.Human Genetics
The study was approved by the review board and ethics committee
of the RWTH Aachen University and the participants gave
informed consent.Linkage Analysis
DNA samples from the index family were used for linkage analysis
of genes, mutant versions of which cause MKS, and related disease
loci. Aminimumof two informative flankingmarkers were typed.5
Primers for PCR amplification were as published by the Genome
Data Base. Microsatellite markers were analyzed on an ABI PRISM
3130 genetic analyzer (Applied Biosystems) with a universal fluo-
resceinated primer ComF.30 Each marker was amplified in a three-
primer PCR reaction in which the forward primer of the two
specific primers was tailed with the sequence corresponding to
ComF (specFcom). A 10:1 molar ratio of primers ComF to specF-
com ensured that specFcomwas exhausted during the early ampli-
fication cycles.Mutation Analysis
We sequenced the exons encoding B9D2 (MIM 611951,
Table S2) on chromosome 19q13 (GenBank NM_030578.3,
NP_085055; mutation numbering þ1 corresponds to the A of
the initiation codon in exon 2). Genomic DNA from a parent
and an affected individual was amplified by PCR with oligonu-
cleotide primers complementary to flanking intronic sequences
(available upon request). PCR products were purified with the
DNA Clean & ConcentratorTM-5 kit (Zymo Research) and
sequenced with ABI BigDye chemistry (Applied Biosystems)
with the PCR primers. Samples were run and analyzed on an
ABI PRISM 3130 (Applied Biosystems). Prediction of the func-
tionality of the identified nonconservative missense mutation
c.301A>C (p.Ser101Arg) was performed as described with a mul-
tisequence alignment of orthologs and several bioinformatic
algorithms.31,321
Morpholino and mRNA Injection of Zebrafish
Embryos
Spice-blocking morpholino (MO) against zebrafish b9d2 and
a control MO (Gene Tools) were injected into 1- or 2-cell stage
zebrafish embryos. After testing 2 ng, 4 ng, and 6 ng of b9d2
MO, we selected 2 ng for subsequent experiments. We observed
similar, but more severe, phenotypes with a translation-blocking
MO directed against the first ATG of b9d2. However, because we
were unable to fully rescue the phenotype, we considered the
MO unreliable and generated a splice-blocking MO. We tran-
scribed mRNA encoding human B9D2 WT and p.Ser101Arg from
pCS2-wtB9D2 and pCS2-B9D2-S101R (SP6 Message Machine, Am-
bion). For functional assays in zebrafish, we coinjected 60 pg wild-
type or mutant B9D2 mRNA with 2 ng b9d2 MO.
Injected zebrafish embryos were classified based on phenotype.
Embryos similar to age-matched controls from the same clutch
were classified as normal. Embryos displaying mildly shortened
body axes, mediolaterally elongated somites, and notochord
imperfections were categorized as Class I. Embryos displaying
severely shortened body axes, mediolaterally elongated somites,
and widened and kinked notochords were categorized as Class II.
Embryo classifications were based on the generalized classification
scheme that has been developed for other ciliopathy loci.33,34 We
compared the proportions of normal and affected embryos
resulting from injections of morpholinos or mRNAs, by means
of the chi-square test.Immunoprecipitation and Immunoblot
COS1 cells were grown on 10 cm diameter plates, transfected
with pGLAP5- or pEF/V5/Frt-Rer1, Mks1, B9d1, B9d2, or B9d2
p.Ser101Arg plasmids via JetPrime (Polyplus-Transfection), and
lysed after 24 hr in a buffer of 50 mM HEPES (pH 7.4), 300 mM
KCl, 1 mM EGTA, 1 mM MgCl2, 10% glycerol, 0.3% Nonidet
P-40, 0.5 mM DTT, and protease and phosphatase inhibitors.
Lysates were cleared by centrifugation at 13,000 3 g for 10 min,
and then incubated with GFP-Trap beads (Chromotek) overnight
at 4C. Beads were washed three times in lysis buffer, resuspended
in 33 SDS-PAGE loading buffer, then denatured at 100C for
5 min. Immunocomplexes were resolved on 4%–15% TGX
gradient gels (Bio-Rad) and transferred to PVDF membrane for
immunoblotting (Bio-Rad).
For Gli3 analysis, E10.5 embryos were lysed in RIPA with
protease and phosphatase inhibitors. Lysates were cleared at
13,000 3 g for 10 min, and protein concentration was assessed
by Bradford assay (Bio-Rad). Proteins were resolved on 7% SDS-
PAGE gels and transferred to PVDF membranes.
For immunoblotting, membranes were blocked with 5% nonfat
dry milk (NFDM) in TBS with 0.1% Tween (TBST), then incubated
with primary antibodies in 5%NFDM-TBST followed by secondary
antibodies in 5% NFDM-TBST. Blots were developed with either
Pico enhanced chemiluminescence (ECL, Pierce) or Western light-
ning ECL (Perkin Elmer). Apparent molecular weights were deter-
mined via full-range rainbow prestained protein standards (Amer-
sham).
Primary antibodies employed were mouse a-GFP (1:1,000, Santa
Cruz Biotechnology), chicken a-GFP (1:1000, Aves), goat a-V5
(1:2,000, AbCam), mouse a-Gli3 (1:5,000, gift from Suzie Scales,
Genentech), and mouse a-tubulin (1:1,000, Sigma). Horse-
radish peroxidase conjugated secondary antibodies were donkey
a-mouse (1:20,000, Jackson Labs), goat a-chicken (1:5,000, Jack-
son Labs), and rabbit a-goat (1:5,000, Santa Cruz Biotechnology).The AMass Spectrometry
NIH 3T3 cell lines harboring stable, single-integrations of pGLAP5
vector or pGLAP5-B9d1 were created with NIH 3T3 Flp-In cells
according to the manufacturer’s instructions (Invitrogen). Fifty
15 cm diameter plates each of pGLAP5 (control) and pGLAP5-
B9d1 stable cells were used for LAP purification as described,35
with the exception that GFP trap beads were used in the purifica-
tion (Chromotek). Purified LAP-complexes were denatured with
33 SDS PAGE sample buffer at 100C for 10 min, and were then
resolved on a 4%–15% Tris-glycine gradient gel (Bio-Rad).
SYPRO ruby (Invitrogen) stained gel bands were excised and
digested with trypsin as reported,36 with the additional use of
ProteaseMax (Promega) for increased peptide recovery and shorter
digestion times. The alkylation reagent used was acrylamide,
providing a propanamide modification.
Nano reversed phase HPLC was done with an Eksigent 2D
nanoLC (Eksigent) with buffer A consisting of 0.1% formic acid
inwater and buffer B 0.1% formic acid in acetonitrile. A fused silica
column self packed with duragel C18matrix (Peeke) was used with
a linear gradient from 5% B to 40% B over 60 min at a flow rate of
600 nL/minute. The nanoHPLC was interfaced with a Michrom
Advance source. The mass spectrometer was an LTQ-Orbitrap
Velos (Thermo Scientific), which was set in data-dependent
acquisition mode to perform MS/MS in the ion trap of the top
eightmost intense ions. A full scan in theOrbitrap of the precursor
ion was done at a resolution of 60,000 at 400 m/z. The .RAW files
were then converted to mzXML format with msconvert script and
searched with a Sorcerer (SageN) processor with Sequest. The data-
base was searched with a precursor mass tolerance of 50 ppm.
All hits with three or more identified peptides in the B9d1LAP
purification and zero or one peptide identified in the control puri-
fication were reported.Modeling of the B9D2 C2 Domain
A model of the B9D2 C2 domain, based on the calcium-free
piccolo C2a domain, was used as a template for electrostatic
surface modeling with adaptive poisson-boltzmann solver
(APBS) in the visual molecular dynamics software (VMD).37,38 A
protein databank (PDB) file of the modeled B9D2 C2 domain
produced by ModBase was converted to a PQR file with PDB2PQR
before applying APBS in VMD.39–41 Software defaults were used in
the electrostatic surface modeling to color positive residues blue
and negative residues red.Results
Mouse B9d1 Mutants Display Developmental Defects
Similar to Those of MKS
Given the importance of Mks1 and B9d2, two genes en-
coding B9 domain proteins, to ciliary structure, we investi-
gated the function of the third member of this family,
B9d1.13,14,42 We obtained a targeted allele of B9d1
(B9d1tm1a(EUCOMM)Wtsi) from the European Conditional
Mouse Mutagenesis Program (EUCOMM) that contains
a gene trap in the second of six introns (Figure S2A). The
resultant mutant allele is predicted to encode a fusion
between the first 44 amino acids and a bgeo reporter. Given
that the wild-type transcript is almost completely abro-
gated in homozygous B9d1 mutant embryos (Figure S2B),merican Journal of Human Genetics 89, 94–110, July 15, 2011 97
Table 1. Survival of B9d1 Embryos
Genotype
Age B9d1þ/þ B9d1þ/ B9d1/
E8.0 10/47 (21) 24/47 (51) 13/47 (28)
E8.5 2/15 (13) 9/15 (60) 4/15 (27)
E9.5 22/95 (23) 48/95 (51) 25/95 (26)
E10.5 35/112 (31) 57/112 (51) 20/112 (18)
E11.5 15/55 (27) 28/55 (51) 12/55 (22)
E12.5 19/67 (28) 33/67 (49) 15/67 (23)
E13.5 28/93 (30) 41/93 (44) 24/93 (26)
E14.5 5/12 (42) 7/12 (58) 0/12 (0)
Embryonic survival scored at the ages listed. Shown is the number of surviving
embryos among the total examined, with percentages in parentheses.the B9d1 gene trap is likely to create a null or near null
allele. In support of this conclusion, we also analyzed
mice homozygous for a deletion of B9d1 exon 3, which
encodes a large portion of the B9 domain, and these
mutants displayed phenotypes indistinguishable from
those homozygous for the gene trap allele (data not
shown).
B9d1 mutants die at approximately E14.5 (Table 1).
Mutant phenotypes were assessed in the strain of deriva-
tion, C57/Bl6, where possible, and in a mixed C57/Bl6-
CD1 strain to observe later stages of development, because
homozygous mutant embryos on the mixed background
die between E17.5 and P1. At E18.5, these B9d1 mutant
mice displayed kidneys that were larger than wild-type
and contained multiple cystic lesions in all of the mutants
examined (n ¼ 5/5; Figure 1A). Dilation and cystic path-
ology was apparent in multiple nephron segments (Fig-
ure S3). Kidney tubules were well ciliated in wild-type
animals, whereas the tubules were enlarged and cilia
were reduced in number and length in B9d1 mutants
(Figure 1B). During liver development, hepatic ductal
plates form as rings around portal veins and are subse-
quently remodeled, positioning bile ducts centrally adja-
cent to portal veins by birth.43 In contrast, ductal plates
persisted as peripheral rings in B9d1 mutant livers at P1,
and hyperplastic portal mesenchyme separated enlarged
bile ducts from portal veins (Figures 1C and 1D). Cilia
were present and similar in length in wild-type andmutant
bile ducts despite the occurrence of ductal plate malforma-
tion (Figure 1E).
B9d1 mutants also developed preaxial polydactyly with
either one or two extra digits, with 92% (n ¼ 23/25) pene-
trance in hindlimbs and 24% (n ¼ 6/25) penetrance in
forelimbs (Figure 1F). We also observed occasional exence-
phaly (n ¼ 3/49; Figure 1G). Thus, B9d1 mouse mutants
display renal cystic dysplasia, the defect most commonly
associated with MKS, as well as ductal plate malformation
of the liver and polydactyly, other prominent characteris-
tics of MKS.98 The American Journal of Human Genetics 89, 94–110, July 15, 201In addition to displaying hallmarks of MKS, B9d1
mutants display dextrocardia with a frequency of 44%
(n ¼ 20/45), suggesting that heart looping is randomized
in the mutant embryos (Figure 1H). We observed addi-
tional phenotypes associated with human ciliopathies in
B9d1 mutants at varying frequencies, including holopro-
sencephaly (Figure 1H), microphthalmia (n ¼ 32/37;
Figure 1G), cleft palate (n ¼ 9/19; Figure S4), ventricular
septal defect (VSD), and thinning of the myocardial wall
(Figure S5).
Randomized heart looping can be due to disruptions in
fluid flow in the embryonic node.44 Because beating cilia
propel nodal flow leftward, mutations in ciliogenic genes
such as Kif3a and Ift88 disrupt left-right patterning.45,46
To assess whether defects in ciliogenesis might underlie
the randomized heart looping observed in B9d1 mutant
mice, we examined nodes with both immunofluorescence
and scanning electron microscopy (SEM). B9d1 mutants
exhibited normal node morphology, but lacked almost all
nodal cilia (Figures 2A–2D); the few cilia that did form
were short and displayed swollen tips (Figure 2D). In addi-
tion to analyzing nodal cilia, we examined the expression
pattern of Lefty genes, early molecular markers, and genes
implicated in the establishment of left-right patter-
ning.28,47–49 In response to nodal flow, Lefty1/2 are
expressed in the floorplate and left lateral plate mesoderm
(LPM) of E8.0 embryos. Expression of Lefty1/2 was absent
in B9d1mutant embryos at E8.0 (n¼ 2/2; Figure 2E), which
is similar to other mutants in which L-R patterning is
disrupted at an early stage of axis specification.44,50–54 We
surmise that the absence of nodal cilia is the likely cause
of the laterality and heart looping defects of B9d1mutants.
Mouse B9d1 Is Required for Hh Signaling and Ciliary
Protein Localization
Cilia are essential for the transduction of several intercel-
lular signals, most notably Hh during neural tube develop-
ment.23,24,55–59 B9d1 mutants lack cilia in the neural tube
(Figure 2F) and exhibit holoprosencephaly (Figure 1H),
a phenotype associated with abrogated Hh signaling.60
Further analysis of the neural tube by transmission elec-
tron microscopy (TEM) revealed that basal bodies in B9d1
mutant embryos dock properly at the apical surface of
the cell yet do not form axonemes (Figures 2G and 2H).
To test whether Hh signaling is affected in B9d1
mutants, we examined patterning of the ventral neural
tube.61 During neural tube development, high levels and
durations of Hh signaling specify the ventral-most cell
fates, including the floor plate, whereas moderate Hh
signaling specifies more dorsal neural subtypes, including
motor neurons.62,63
Molecular analysis of FoxA2 expression, a marker of the
floor plate, indicated that the floor plate is reduced in B9d1
mutants (Figure 3A). Similar to the floor plate, high levels
of Hh signaling are required for the induction of adjoi-
ning V3 interneuron precursors.64,65 Analysis of Nkx2.2,
a marker of V3 interneuron precursors, revealed reduced1
Figure 1. B9d1 Mutants Display Defects
Similar to Those of MKS
(A) Coronal sections of E18.5 kidneys
stained with H&E. Mutant kidneys are
larger and contain multiple cysts. Scale
bar represents 500 mm.
(B) P1 kidney tubules stainedwith amarker
of cilia, acetylated tubulin (AcTub, red),
and nuclei (DAPI, blue). B9d1 mutant
tubules possess fewer cilia than wild-type
tubules. Dotted lines mark the borders of
tubules. Scale bar represents 25 mm.
(C) P1 liver sections stained with H&E.
Scale bar represents 100 mm.
(D) Liver sections stained with a marker of
bile ducts, Sox9 (red), E-cadherin (green),
and nuclei (DAPI, blue). The ductal plate
(arrowheads) fails to remodel in mutant
livers, resulting in an abundance of portal
mesenchyme (arrow) and separation of
bile ducts (asterisks) from the central
portal vein (pv). Scale bar represents
50 mm.
(E) Bile ducts stained for cilia (AcTub, red)
and nuclei (DAPI, blue). Cilia are present
in mutant bile ducts. Scale bar represents
10 mm.
(F) E13.5 forelimbs (top) and hindlimbs
(bottom) stained with alcian blue,
showing preaxial polydactyly.
(G) Left lateral view of E11.5 embryos.
B9d1mutants exhibit reduced telencepha-
lons, microphthalmia, and occasional ex-
encephaly (arrow).
(H) Frontal view of E10.5 embryos. B9d1
mutants display midline facial defects,
randomized heart looping, and holopro-
sencephaly.
Scale bars for (F)–(H) represent 1 mm.expression in B9d1mutants (Figure 3B). Additionally, B9d1
mutants showed a variable reduction in the number of
motor neurons, as indicated by Islet1/2 expression
(Figure 3C). The loss or reduction of ventral neural marker
expression inB9d1mutantswasaccompaniedby theventral
expansion of Pax6 expression (Figures 3A–3C), normally
restricted to the dorsal neural tube by Hh signaling.66
Together, these results indicate that B9d1 is required for
high and moderate level Hh signaling in the neural tube.
In addition to their roles in promoting activation of the
Hh transcriptional program, cilia are essential for the for-
mation of the transcriptional repressor form of Gli3
(Gli3R).22,59 Unlike the neural tube, Shh controls antero-
posterior limb bud patterning principally by inhibiting
the formation of Gli3R. Shh is secreted from the zone of
polarizing activity in the posterior of the limb bud,
creating an opposing gradient of Gli3R decreasing fromThe American Journal of Humanterior to posterior.67 Loss of Gli3
results in polydactyly, similar to Shh
gain of function.68,69 Mice with
defects in ciliogenesis can display
preaxial polydactyly, attributable to
defects in Gli3R formation.22,59,70,71The presence of preaxial polydactyly in B9d1 mutants
(Figure 1F) was consistent with defective Gli3 processing.
B9d1 mutants typically developed one or two supernu-
mary preaxial digits on hindlimbs and occasionally on
forelimbs, a limb phenotype more pronounced than that
reported for Mks1 mutants.13,15 To assess whether B9d1 is
required for Gli3 processing, we analyzed Gli3 in B9d1
heterozygote and mutant mouse embryo lysates. Full-
length Gli3 was stabilized in mutant embryos compared
to wild-type (Figure 4A), consistent with reduced Hh
responsiveness.
In response to Hh ligand, Smoothened (Smo), a positive
regulator of Hh signaling, translocates into primary cilia
and activates the pathway.20 To examine further the role
of B9d1 in Hh signal transduction, we analyzed the locali-
zation of Smo to cilia in response to Smo AGonist (SAG).
Similar to the cilia status of bile ducts, mouse embryonican Genetics 89, 94–110, July 15, 2011 99
Figure 2. B9d1 Mutant Nodes and Neural Tubes Have Few and Abnormal Cilia and Mutants Do Not Express an Early Marker of LR
Patterning
(A) Ventral view of E8.0 nodes with anterior oriented upward, depicting cilia (AcTub, green), basal bodies (Ninein, red), and nuclei (DAPI,
blue). Scale bar represents 50 mm. Few cilia are present in B9d1 mutant nodes, whereas the number of basal bodies is unaffected.
(B–D) Scanning electron micrographs of E8.0 nodes reveal a reduction in the number of cilia in B9d1 mutants.
(B) The morphology of the node is normal in B9d1 mutants. Scale bar represents 20 mm.
(C) There is a dramatic reduction in the number of cilia in B9d1 mutant nodes. Scale bar represents 5 mm.
(D) The few cilia that form in B9d1 mutant nodes are short and can display bulges at their distal tips. Scale bar represents 2 mm.
(E) Frontal view of E8.0 embryos stained for expression of Lefty1/2. Expression is absent in the midline and left lateral plate mesoderm of
B9d1 mutant embryos. Scale bar represents 500 mm.
(F) Transverse sections of E10.5 embryos showing the ventral neural tube and perineural mesenchyme stained with a marker of cilia
(Arl13b, green) and nuclei (DAPI, blue). Scale bar represents 50 mm. B9d1mutants show a reduction in the number of cilia in both tissues.
(G and H) Transmission electron micrographs of cilia in E9.5 neural tubes. Scale bar represents 500 nm.
(G) Serial sections through a B9d1 heterozygous E9.5 neural tube cilium.
(H) Serial sections through a B9d1mutant E9.5 neural tube cilium reveal a docked basal body, a disrupted axoneme, and a bulging ciliary
membrane.fibroblasts (MEFs) derived from B9d1 mutant embryos
were ciliated (Figure 4B). In response to SAG treatment,
Smo localized to cilia in WT MEFs but not B9d1 mutant100 The American Journal of Human Genetics 89, 94–110, July 15, 20MEFs (Figure 4B; Figure S6), consistent with reduced Hh
responsiveness. We also quantified the change in mRNA
levels of Gli1 and Ptc1, general transcriptional targets of11
Figure 3. B9d1 Is Required for Hh-Dependent Neural Tube
Patterning
Transverse sections of E9.5 embryos stained for expression of Pax6
(red) and, in green, FoxA2 (A), Nkx2.2 (B), or Islet1/2 (C). Nuclei
are visualized with DAPI (blue).
(A) B9d1 mutants show reduction of the floorplate marker FoxA2
and ventrally expanded Pax6 expression.
(B) B9d1 mutants have reduced expression of the V3 interneuron
precursor marker Nkx2.2.
(C) Expression of motor neuron marker Islet1/2 is reduced and
ventrally shifted in B9d1 mutants.
Scale bar represents 100 mm.
The AHh signaling, in MEFs treated with SAG. B9d1 mutant
MEFs treated with SAG showed blunted increases in Gli1
and Ptc1 activation as compared to WT SAG-treated MEFs
(Figures 4C and 4D). Together, these results indicate that
B9d1 is required for robust responsiveness to Hh signals
even in cells that do not require B9d1 for ciliogenesis.
Given the failure of Smo to move to MEF cilia in
response to SAG, we asked whether other ciliary proteins
might fail to localize properly to the cilia of B9d1 mutant
MEFs. Whereas the intraflagellar transport protein Ift88
localized to bothWTand B9d1mutant MEF cilia, the small
GTPase Arl13b and the adenylate cyclase ACIII were found
only in WT MEF cilia (Figures 4E–4G; Figure S6).22,55,72
This protein localization defect is similar to that seen
upon disruption of Tctn1, Tctn2, Tmem67, or Cc2d2a,
components of a larger transition zone complex that also
contains B9 proteins (Table S3).73 Thus, B9d1 is required
for the ciliary localization of a discrete subset of proteins,
including Smo, Arl13b, and ACIII.B9D2 Is a Candidate MKS Locus
B9d2, a B9 protein related to B9d1, localizes to the basal
body and the ciliary axoneme, and loss of B9d2,
either in vivo or in cultured cells, results in ciliogenic
defects.11,14,42 In addition, conditional inactivation of
B9d2 in the kidney produces cysts similar to those of
Mks1 and B9d1mutant mice.13–15 The phenotypic overlap
observed betweenMks1, B9d1, and B9d2mutant mice, and
the evolutionarily co-occurrence of these genes, suggested
that human B9D1 and B9D2 variants could cause MKS.
To test this hypothesis, we used a combination of homo-
zygositymapping and candidate gene sequencing to screen
B9D1 andB9D2 in 96unrelatedMKSpatients.No regions of
homozygosity overlappingwithB9D1 segregatedwithMKS
phenotypes in our patient cohort, and sequencing analysis
without bias for linkage or homozygosity did not identify
any nonsynonymous changes that would be consistent
with a pathogenic role of this gene in our cohort of MKS
patients. We note, however, that a recent study reported
a B9D1 mutation in an individual with MKS.74 We identi-
fied a fifth-degree consanguineous multiplex family from
Surinam with Indian-Pakistani background (Figure 5A), in
which two affected fetuses displayed overlapping pheno-
types including cystic kidneys, ductal plate malformation,
polydactyly, and occipital encephalocele (Figures 5B–5M).
Linkage analysis demonstrated identical homozygous
haplotypes in both patients (Figure 5A) that were distinct
from the haplotypes of the unaffected son (Figure 5A), but
no regions of homozygosity in other known MKS disease
genes. Sequencing revealed a homozygous, nonconserva-
tive missense mutation (c.301A>C) in B9D2 resulting in
a serine to arginine substitution (p.Ser101Arg) in both
affected individuals (Figure 5N). This change segregated
with the MKS phenotype in this family, has not been
described in all accessible databases of human genome vari-
ation, and was not present among 300 ethnically matchedmerican Journal of Human Genetics 89, 94–110, July 15, 2011 101
Figure 4. Hh Signaling and Protein
Localization Defects in B9d1 Mutants
(A) Gli3 processing was assessed in E10.5
B9d1 heterozygote or mutant embryo
lysates. Full-length Gli3 is stabilized in
mutant lysates compared to the heterozy-
gotes.
(B) B9d1 wild-type and mutant MEFs
stained for cilia (AcTub, blue), basal bodies
(g-Tubulin, green), and Smo (red) in
response to SAG treatment. Smo fails to
localize to B9d1 mutant MEFs treated
with SAG. Scale bar represents 2.5 mm.
(C and D) Gli1 and Ptc1 mRNA levels of
B9d1 wild-type and mutant MEFs stimu-
lated with SAG. The transcriptional
response to SAG treatment is abrogated
in B9d1 mutant MEFs. y axis values repre-
sent the fold change of mRNA compared
to wild-type MEFs treated with vehicle
only. Error bars represent the standard
deviation. Asterisk indicates p < 0.0001.
(E–G) B9d1 wild-type and mutant MEFs
stained for cilia (AcTub, blue), basal bodies
(g-Tubulin, green), and the ciliary proteins
(red) Ift88 (E), Arl13b (F), and ACIII (G).
Arl13b and ACIII fail to localize to B9d1
mutant cilia.
Scale bar represents 2.5 mm.control chromosomes or 388 control chromosomes from
other ethnic backgrounds.
Residue 101 is invariantly serine in chordate B9D2
proteins and is either a serine or threonine in the B9D2
orthologs of ciliated protists Chlamydomonas, Naegleria,
and Batrachochytrium (Figure 5O). This high degree of con-
servation suggests that serine 101 is important for B9D2102 The American Journal of Human Genetics 89, 94–110, July 15, 2011function and that substituting this
small, polar,nonionizable residuewith
a large, basic residue such as arginine
may not be tolerated (Figure S7). Simi-
larly, in silico analysis predicted that
thismutation is pathogenic (Table S1).
The Candidate MKS p.Ser101Arg
Mutation Causes Loss of B9D2
Function
We have shown previously that mor-
pholino (MO) suppression of mks1 in
zebrafish results in developmental
defects that include shortened body
axis, broad notochords, long, thin
somites, and failure of tail exten-
sion.34 Further, we and others have
demonstrated the tractability of
in vivo rescue in this system to deter-
mine the pathogenic effect of alleles
found in ciliary genes with high speci-
ficity and sensitivity.75–77 To test the
pathogenicity of the b9d2 MKS allele,
we generated a splice-blocking MOagainst zebrafish b9d2 and attempted rescue with control
or mutant human B9D2 mRNA. Injection of increasing
amounts (2, 4, 6 ng) of b9d2MO resulted in dosage-depen-
dent phenotypes that can be grouped into three classes
based on previously reported criteria (normal, class I, and
class II).34 Class I embryos displayed mildly shortened
bodyaxes,mediolaterally elongated somites, andnotochord
Figure 5. A B9D2 Mutation Is Associated with MKS
(A) Pedigree structure of a fifth-degree consanguineous multiplex family, which includes two affected MKS individuals harboring
a homozygous point mutation in B9D2 (c.301A>C).
(B and C) Frontal and lateral views of an affected fetus aborted at the 17th gestational week because of occipital encephalocele.
(D and E) Polydactyly of the hands and feet.
(F) H&E-stained kidney section shows renal cysts.
(G) H&E-stained liver section reveals ductal plate malformation.
(H) Cytokeratin-19 staining shows defective modeling and persistence of bile duct remnants, confirming the ductal plate malformation
(asterisks).
(I and J) Affected fetus aborted at the 29th gestational week. Postmortem analysis confirmed anencephaly, with occipital encephalocele,
sacral dimple, and postaxial polydactyly of both hands and feet.
(K) H&E-stained cystic kidney section shows reduction of glomeruli and tubuli.
(L) H&E-stained kidney section at the level of the medulla showing some small cysts (arrows). Compared to normal fetal kidney control
samples, the affected renal tissue showed less glomeruli. The Bowman’s capsule was not clearly dilated and the proximal renal tubuli
seemed normally developed. Immunohistochemistry with epithelial membrane antigen (EMA) and CD15 antibodies (data not shown)
demonstrated that cyst formations mainly affected the distal tubuli, although some small renal cysts were also seen at the medullary
level.
(M) H&E-stained liver section reveals fetal hematopoesis and ductal plate malformation (asterisks).
(N) B9D2 sequence traces are shown for an affected fetus (bottom) and one of the parents (top). Arrow indicates position of homozygous
mutation (c.301A>C).
(O) ClustalWalignment of B9D2 protein sequences from diverse ciliated eukaryotes reveals conservation of either serine or threonine at
the position corresponding to Ser101 of the human sequence (highlighted). Asterisks indicate identical residues, colons indicate
conserved residues, and periods indicate semiconserved residues.imperfections; class II embryos displayed severely shortened
body axes, mediolaterally elongated somites, and widened
and kinked notochords (Figure 6A; Figure S8).The AThe specificity of the MO-induced phenotypes was
confirmed by coinjection of human B9D2 mRNA. Upon
masked scoring of 50–150 embryos per injection, wemerican Journal of Human Genetics 89, 94–110, July 15, 2011 103
Figure 6. B9D2 p.Ser101Arg Fails to
Rescue Zebrafish Phenotypes Caused by
Suppression of b9d2
(A) Injection of MOs against b9d2
produces defects in zebrafish development
including shortened body axis, widened
and kinked notochord (asterisk), and
broadened somites (arrow).
(B) Graph of the frequency of class I and II
phenotypes among zebrafish embryos.
Whereas coinjection of wild-type human
B9D2 RNA (WT RNA) reduces the fre-
quency of developmental defects caused
by 2 ng b9d2 MO, B9D2 S101R RNA does
not rescue the phenotype (b9d2 MO þ
S101R).observed that whereas 29% of the b9d2 morphants were
designated as class I and 21% were class II, coinjection of
b9d2morpholino with 60 pg human B9D2mRNA reduced
the prevalence of class I to 14% and of class II to 4%. In
contrast, coinjection of b9d2 morpholino with 60 pg of
human B9D2 c.301A>C mRNA yielded morphants of
which 33% were scored as class I and 14% were class II.
The failure of B9D2 c.301A>C to reduce the frequency of
b9d2 morpholino phenotypes suggests that the MKS-asso-
ciated mutation is a strong hypomorphic or functional
null allele (Figure 6B).
Effect of the B9D2 Mutation on Protein Function
To investigate the pathogenicity of the B9D2mutant allele
and the mechanisms by which it may result in ciliary
dysfunction and human disease, we explored the potential
consequences of the p.Ser101Arg amino acid substitution
in mammalian cells. B9D2 has been shown to localize
primarily to the basal body and, under certain conditions,
to the axoneme of the primary cilium.11 We therefore
tested whether introduction of the Arg101 residue affects
B9D2 localization. Upon expression of GFP-B9D2 and
GFP-B9D2 S101R in hTERT-RPE1 cells, we found that
both localize to the basal body (Figure 7), renderingmisloc-
alization an unlikely cause of disease and pointing instead
to potential biochemical causes.
The phenotypic overlap caused by loss of any of the
three mouse B9 proteins raised the possibility that the B9
proteins promote ciliogenesis by acting together in
a nonredundant fashion. Similarly, the presence of MKS-
associated mutations in B9D1, B9D2, and MKS1 suggests
that these proteins may function cooperatively in hu-
mans, reminiscent of the related ciliopathy, Bardet-Biedl104 The American Journal of Human Genetics 89, 94–110, July 15, 2011syndrome (BBS [MIM 209900]), in
which the products of several causa-
tive genes can form a complex.78 To
investigate whether B9 proteins
might similarly form a MKS-related
complex, we assessed whether tagged
B9 proteins coimmunoprecipitated.
GFP-tagged versions of Mks1, B9d1,and B9d2 coimmunoprecipitated V5-tagged versions of
the other B9 proteins (Figure 8). GFP-tagged B9 proteins
did not coimmunoprecipitate with the V5 vector or a V5-
tagged control protein, Rer1, indicating that the interac-
tion of the B9 proteins with each other is specific.
To confirm further the observed interactions, we created
NIH 3T3 cell lines harboring stable, single integrations of
a control plasmid expressing the localization and affinity
purification (LAP) tag (pGLAP5) or a plasmid expressing
B9d1 with a carboxy-terminally fused LAP (pGLAP5-
B9d1). We tandem affinity purified LAP proteins from the
control and B9d1-LAP-expressing cells, separated them
by gel electrophoresis, sectioned the gel lanes, and sub-
jected them to mass spectrometry.29,35 Mass spectrometric
analysis detected abundant peptides of Mks1 (50 peptides
with 37% coverage) and B9d2 (32 peptides with 42%
coverage) among the proteins that copurified with B9d1-
LAP. We also identified a number of interacting proteins
that have been suggested recently to be part of a larger
transition zone complex functioning within the cilium
(Table S3).73
To determine how the p.Ser101Arg mutation affects
B9D2 activity, we asked whether this mutation alters B9
protein complex formation. Reciprocal coimmunoprecipi-
tations indicated that B9d2 p.Ser101Arg failed to interact
with Mks1, without compromising its interaction with
B9d1 (Figure 8). These results indicate that the B9 proteins
interact physically and that the MKS-associated mutant
form of B9d2 disrupts its interaction with Mks1, thus
compromising the integrity of this ciliogenic complex.
Therefore, we propose that mutations that disrupt the
interactions among components of the B9 complex result
in human MKS.
Figure 7. Localization of Wild-Type
B9D2 and B9D2 S101R
hTERT-RPE1 cells expressing GFP-tagged
wild-type B9D2 or B9D2 S101R (green).
Expressions of both are enriched at the
base of cilia (AcTub, red, arrows). Nuclei
are visualized with DAPI (blue). Scale bar
represents 10 mm.Discussion
In the last decade, our understanding of the role of
primary cilia in human disorders has benefited from the
identification of a burgeoning group of ciliopathy-associ-
ated genes. In this study, we showed that disruption of
B9d1 in the mouse perturbs ciliogenesis and ciliary
protein localization, abrogates Hh signaling, and results
in phenotypes that fall on the severe end of the ciliopathy
clinical spectrum. In addition, we identified a non-
conservative missense mutation in B9D2 in individuals
affected with MKS. Finally, we demonstrated that the B9
domain containing proteins physically interact and
that the MKS-associated mutant form of B9d2 has dimin-
ished function and reduced capacity to interact with
Mks1, previously implicated in MKS.2,79 Together, these
results suggest that a complex of B9 proteins coopera-
tively supports mammalian ciliogenesis and ciliary pro-
tein localization, and abrogated complex function results
in MKS.
B9d1 Is Essential for Ciliogenesis, Ciliary Protein
Localization, and Hh Signal Transduction
Ciliary defects compromise the response to Hh signals in
vertebrates by abrogating the ability of Smo to activate
both Gli2 and Gli3R formation.19,59 The Hh-related
phenotypes of B9d1 mutants include dorsalization of the
neural tube consistent with decreased Gli2 activity, as
well as limb bud patterning defects associated with disrup-
ted Gli3 processing. In MEFs, B9d1 is dispensible for cilio-
genesis but is required for robust response to the Hh
pathway activator SAG. This probably reflects the require-
ment for B9d1 for the movement of Smo in response to
pathway activation and supports the contention that
some MKS phenotypes, such as polydactyly, are due to
disruptions in Hh signal transduction.15The American Journal of HumaBecause cilia may participate in
multiple signaling pathways, other
manifestations of MKS may be due to
defects in intercellular communica-
tion apart from Hh signaling.33,80–82
In addition to Smo, B9d1 is essential
for the ciliary localization of Arl13b
and ACIII. Similar defects in ciliary
membrane composition are observed
in mouse mutants affecting B9d1-in-
teracting proteins.73 It is likely thatalterations in ciliary membrane composition affect diverse
ciliary functions, resulting in some of the pleiotropic
phenotypes associated with MKS.
Mutation of B9D2 Is Associated with MKS
We detected a homozygous missense mutation affecting
a highly conserved residue of B9D2 in the affected MKS
individuals of a single pedigree, suggesting that B9D2 is
essential for human development. In addition to the
human genetic data, the failure of B9D2 bearing the
p.Ser101Arg mutation to rescue zebrafish b9d2 morphants
or to interact with Mks1 indicates that this mutation abro-
gates function.
A significant fraction of cases of other genetically hetero-
geneous ciliopathies, such as nephronophthisis and BBS,
are caused by private mutations.83–85 Our work indicates
that this may be true for MKS as well. Human genetic
studies with limited pedigrees are insufficient to prove
the causality of alleles and, by extension, the causal role
of specific genes in the phenotype. However, testing the
allele in a physiologically relevant system provides insight
into its function. In the case of the MKS-associated allele of
B9D2, we used three approaches to provide evidence of
causality: human genetics, in vivo rescue, and biochemical
interaction data.
Although we did not detect B9D1 mutations in our
cohort of 96 MKS patients, a recent study identified
B9D1 mutations as a cause of MKS.74 If B9D1 mutations
result in early gestational lethality, as exhibited by the
B9d1 mutant mice, B9D1 mutations detected in postnatal
MKS cases may not reflect the prevalence of the alleles.
The B9 Domain of B9D2 Promotes Interaction
with MKS1
It is striking that the B9 domain-containing proteins are
found only in organisms that form cilia and that all B9n Genetics 89, 94–110, July 15, 2011 105
Figure 8. B9 Proteins Form a Complex
and B9d2 S101R Fails to Interact with
Mks1
Coimmunoprecipitation of epitope-tagged
B9 proteins. Immunoprecipitation of
GFP-tagged Mks1 (A), B9d1 (B), B9d2 and
B9d2 S101R (C) revealed interactions
with V5-tagged Mks1, B9d1, B9d2, and
B9d2S101R but not vector alone or
a nonspecific (NS) control protein, Rer1.
In contrast to all other B9 protein combi-
nations, B9d2 S101R did not interact
with Mks1.proteins are involved in ciliary functions in both C. elegans
and vertebrates.11–15 The p.Ser101Arg mutation of B9D2
identified in MKS individuals occurs within the B9
domain, suggesting that it is critical to protein function.
The B9 domain is related to the C2 domain involved in
calcium-dependent lipid binding present in several other
MKS proteins, including MKS5 (RPGRIP1L) and MKS6
(CC2D2A).86 Despite the possibility that MKS1, B9D1,
and B9D2 suggests shared biochemical activities with C2
domain proteins, the overlapping ciliary defects exhibited
by the mouse B9 mutants suggest that they are not func-
tionally redundant either with each other or with C2
domain proteins.13,15
The MKS-associated mutation in the B9 domain of B9D2
does not destabilize the protein, interfere with its localiza-
tion to the ciliary base, or compromise its interaction with
B9d1. Instead, the inability of the mutant form of B9d2 to
physically interact with Mks1 reveals that the mutation
compromises formation of the B9 protein complex. These
results suggest that B9 domains may support protein-
protein interactions and that disruption of the B9 protein
complex may underlie some forms of MKS.
B9 Proteins Have Nonredundant Functions
in Development
In support of the contention that B9 proteins function
together in a complex, B9d1 mutant mice display pheno-
types associated with the MKS1 variant of MKS, including
cleft palate, holoprosencephaly, microphthalmia, and106 The American Journal of Human Genetics 89, 94–110, July 15, 2011polydactyly.2,16–18 Furthermore, the
two MKS fetuses harboring B9D2
mutations displayed polydactyly. The
late gestational MKS fetus, in addition
to occipital encephalocele, exhibited
anencephaly and a sacral dimple,
reflecting neural tube closure defects.
Mutations in each B9 gene in
humans can be associated with MKS,
and loss of each B9 protein in mice
causes phenotypes consistent with
MKS.2,13–15,74 However, the descrip-
tions of the three B9 mouse mutant
phenotypes are not identical. The
B9d2-null phenotype has not beendescribed, but conditional deletion of B9d2 in the nervous
system and kidneys caused kidney cysts, hydrocephalus,
and a loss or stunting of cilia in the CNS.14
Two distinct Mks1 mutations cause cystic kidneys, poly-
dactyly, neural tube defects, reduced skull ossification,
other skeletal abnormalities, and hepatic defects. Mks1krc
is a splice-site mutation that results in deletion of the B9
domain, and Mks1del64-323 is an in-frame deletion of exons
3–10 that removes the first nine amino acids of the B9
domain.13,15 Despite extensive phenotypic similarities,
the two mutants are not indistinguishable. At E10.5,
Mks1krc mutants did not display gross abnormalities,
whereas Mks1del64-323 mutants displayed expansion of the
mesencephalic flexure, reduced telencephalon size, and
microphthalmia, similar to B9d1 mutants.13,15 Moreover,
Mks1del64-323 mutants exhibited neural tube patterning
defects similar to those of B9d1 mutants and more
profound than those of Mks1krc mutants.13,15 Because
Mks1krc phenotypes were assessed on a C3H or mixed
C3H/CD1 background and Mks1del64-323 phenotypes were
assessed on a C3H or C57Bl/6 background (C. Lo, personal
communication), the phenotypic differences may reflect
differences in allele strength or modification by back-
ground-dependent loci.13,15
The Relationship of Ciliary Dysfunction
and Ciliopathies
In addition to MKS, defects in the function of primary cilia
are thought to underlie related disorders including BBS,
Leber congenital amaurosis (LCA [MIM 204000]), and
Senior-Løken syndrome (SLSN [MIM 266900]). Several of
these disorders share retinal degeneration as a feature but
include other characteristics such as obesity, polydactyly,
and renal abnormalities (BBS), midface hypoplasia (LCA),
or nephronophthisis, a cystic kidney disorder (SLSN).
Further examples of ciliopathies include Joubert syndrome
(JBTS [MIM 213300]), characterized by hypoplasia of the
cerebellar vermis, and Orofaciodigital syndrome (OFD
[MIM 311200]), characterized by malformation of the
face, mouth, and digits. It is not clear how ciliary dysfunc-
tion results in such diverse phenotypes.87
Moreover, some ciliopathy genes display extensive
allelism. For example, mutations in CEP290 are associated
with MKS, JBTS, SLSN, LCA, and BBS.88 Although some
CEP290 mutations may affect discrete functions or
compromise activity to different degrees, other CEP290
mutations are associated with more than one ciliopathy,
suggesting that modifier effects may account for the
distinct resultant phenotypes.88,89
In support of the possibility that ciliary modifier loci
have strong effects on expressivity, we observed that
mouse B9d1 mutants with C57/Bl6 or mixed CD1-C57/
Bl6 backgrounds displayed distinct phenotypes. It will be
interesting to assess whether other B9D1 or B9D2 muta-
tions underlie ciliopathies related to MKS, such as JBTS,
and whether weaker alleles of B9 genes modify other cilio-
pathies.
A second possible explanation for the origins of different
ciliopathy phenotypes is that different ciliogenic protein
complexes have distinct functions, affecting ciliogenesis
to different extents or in different tissues. In support of
this possibility, B9 mutants display tissue-specific defects
in ciliogenesis and ciliary protein mislocalization. For
example, in mouse B9d1 mutants, cilia are absent in the
node and neural tube, reduced in number and length in
cystic kidneys, and present in bile ducts and MEFs. Simi-
larly, in mouse Mks1 mutants, cilia are reduced in number
and length in the node, limb buds, and neural tube, but
not in lung airways and bile ducts.15
As in the mammalian bile duct, B9 proteins are not
required for ciliogenesis in C. elegans, as shown by the
fact that nematodes mutant for the orthologs of Mks1,
B9d1, B9d2, or a combination of all three do not display
overt structural ciliary defects.11,12 The C. elegans orthologs
of B9 proteins are, however, required for cilia-dependent
sensory functions.12
Thus, B9 proteins are required for the formation of cilia
in some tissues and organisms and are required for ciliary
function in others. B9d1 is essential for the localization
of a subset of ciliary proteins, so defects in ciliary protein
composition are likely to underlie some intercellular
signaling abnormalities in mouse B9 mutants. The simi-
larity of mouse Mks1 and B9d1 mutant phenotypes to
human MKS suggests that MKS may be caused not by the
absence of cilia, but by tissue-specific ciliary loss and
dysfunction.The ASupplemental Data
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